The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing examining the impact of health care consolidation, which featured academic witnesses. In a letter submitted to the committee, AHA Executive Vice President Tom Nickels said, “If there was ever any doubt that the health care landscape is changing dramatically, one has to look no further than the recent announcements that CVS seeks to acquire Aetna; Amazon, Berkshire Hathaway and JP Morgan Chase & Co partnering on employee health care; and UnitedHealth Group embarking on a physician acquisition spree. The hospital field has long anticipated this disruption and has sought to participate by replacing an outdated ‘siloed’ health care system with a continuum of care to improve coordination and quality and reduce costs for patients. Building a continuum demands that providers are more integrated. This can take many forms, involving mergers with other hospitals, acquisition or employment of physicians and clinical integration, among other arrangements.” For more on the issue and AHA’s take, see today’s AHA Stat blog post.

Related News Articles

Headline
The AHA July 15 commented to Sens. Sheldon Whitehouse, D-R.I., and Bill Cassidy, R-La., responding to a request for information based on the Pay PCPs Act,…
Headline
The House Appropriations Committee July 10 voted 31-25 to approve legislation that would provide $185.8 billion in funding for the departments of Labor, Health…
Headline
The House Energy and Commerce Committee June 12 passed AHA-supported legislation during a markup of bills that passed the Health Subcommittee in May. The…
Headline
The AHA praised House and Senate leaders in letters June 12 for reintroducing the Improving Seniors’ Timely Access to Care Act, bipartisan legislation that…
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Headline
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent…